Microcirculation

Microcirculation is a peer-reviewed journal published by Wiley on behalf of three societies, The Microcirculatory Society, the Australia & New Zealand Microcirculation Society and the Japanese Society for Microcirculation. It has carried work on the smallest blood and lymph vessels since 1994, and its papers run from whole-animal and human studies down to organ, cellular and molecular experiments. The 2025 Journal Impact Factor is 2.4 and the CiteScore is 3.7.《微循环》是一份同行评审期刊，由 Wiley 代表三家学会出版，分别是 The Microcirculatory Society, Inc.、澳大利亚与新西兰微循环学会以及日本微循环学会。1994 年创刊以来，刊物一直刊发最细小血管与淋巴管方面的研究，稿件从整体动物与人体研究，一直延伸到器官、细胞与分子层面的实验。2025 年期刊影响因子为 2.4，CiteScore 为 3.7。

Scope

• The remit is original research that reports important new information about vascular and lymphatic microcirculation, whether the observation is made in an intact animal or human, in an organ, in a cell or at the molecular scale.接收的稿件为原创研究，须在血管微循环与淋巴微循环方面给出重要的新信息，观察对象可以是完整动物与人体，也可以是器官、细胞或分子尺度。

• Physiology and biophysics sit next to bioengineering and genetics among the approaches the journal expects, and cell biology, biochemistry and molecular biology are equally welcome.刊物接受的研究路径覆盖生理学与生物物理学，生物工程与遗传学同样在内，细胞生物学、生物化学与分子生物学也在其中。

• Clinical and translational methods count as a route into the subject in their own right, not as an appendage to laboratory findings.临床与转化方法本身就构成一条进入这一课题的路径，不作实验室发现的附庸。

• State-of-the-art reviews cover frontier areas of the field and the advances in technique that open them up, and most are invited for a special issue or a meeting.现状综述覆盖学科前沿，也覆盖打开这些前沿的技术进展，多数由编辑部为专刊或会议约请。

• Angiogenesis and vascular growth and remodelling are named interests, taking in the sprouting, pruning and stabilization of new vessel networks.血管新生与血管生长重塑是刊物点明的方向，新血管网络的出芽、修剪与稳定都落在其中。

• Permeability, transport and exchange form a single heading, which keeps barrier function and solute movement in one frame.通透性与转运、交换合成一项，屏障功能与溶质移动因此共处一个框架。

• Lymphatic biology has a heading of its own, from the contractility of collecting vessels through lymphangiogenesis to the immune traffic that passes along lymphatic routes.淋巴生物学单独占一项，从集合管的收缩性，经淋巴管新生，一直到沿淋巴途径通行的免疫细胞运输。

• Rheology and biorheology bring in blood viscosity, red cell deformability and the mechanics of flow in vessels only a few cells across.流变学与生物流变学纳入血液黏度、红细胞变形能力，以及只有几个细胞宽的血管内的流动力学。

• Endothelial cell biology is listed separately, and it runs from shear sensing and junctional assembly to the transcriptional programmes that fix a vessel's identity.内皮细胞生物学单列一项，范围从剪切力感知与连接组装，一直到锁定血管身份的转录程序。

• Endothelial exchange with parenchymal cells carries much of the published work, and the same heading covers smooth muscle cells, leukocytes and platelets.内皮与实质细胞之间的往来承载了已发表工作的大部分，同一项下也包括平滑肌细胞、白细胞与血小板。

• Regulation of vasomotor tone has its own line, which puts arteriolar and venular control of resistance and capacitance under one label.血管舒缩张力的调控另有一行，微动脉与微静脉对阻力与容量的控制由此归入同一标目。

• Oxygen and carbon dioxide exchange appears as a subject in itself, tied to the capillary-tissue interface and to the matching of perfusion with demand.氧与二氧化碳交换自成一项，关注毛细血管与组织之间的界面，以及灌注与需求之间的匹配。

• Imaging and morphology of microvascular structure close the list of core interests, with intravital microscopy, corrosion casting and three-dimensional reconstruction all inside it.微血管结构的成像与形态学收束核心方向清单，活体显微观察、血管铸型与三维重建都在其内。

• Papers on new techniques and instruments are accepted when the method opens a question that the existing toolkit cannot reach.新技术与新仪器的论文同样接收，前提是这套方法能打开现有工具触及不到的问题。

History

• The first volume appeared in 1994 under the Chapman & Hall imprint in New York, and the National Library of Medicine records coverage from volume 1, issue 1, dated April 1994.第 1 卷于 1994 年问世，出版方为纽约的 Chapman & Hall，美国国家医学图书馆的收录记录从第 1 卷第 1 期起算，时间为 1994 年 4 月。

• Volume 33 carries the 2026 issues, which fixes volume 1 at 1994 and leaves no break in the numbering since the founding year.2026 年的各期编入第 33 卷，据此可以确认第 1 卷即 1994 年，创刊以来卷号一直没有中断。

• The title started as the official journal of The Microcirculatory Society, as the National Library of Medicine catalogue still records it, and the current masthead names two further societies, the Australia & New Zealand Microcirculation Society and the Japanese Society for Microcirculation.刊物起初是 The Microcirculatory Society 的会刊，美国国家医学图书馆的目录至今仍这样著录，现行刊头另外列出两家学会，即澳大利亚与新西兰微循环学会和日本微循环学会。

• Ownership passed from Chapman & Hall to Wiley-Blackwell, whose Malden, Massachusetts imprint replaced the New York one in the catalogue record.出版方后来由 Chapman & Hall 转到 Wiley-Blackwell，目录中的出版地也从纽约改为马萨诸塞州的马尔登。

• Frequency reached eight issues a year in 2004, and the National Library of Medicine has carried that figure since.刊期在 2004 年达到每年 8 期，美国国家医学图书馆此后一直沿用这一著录。

• Volume 30 folded the usual double issues into combined numbers 2–3 and 5–6, a compression that left the yearly total at eight.第 30 卷把惯常的双期并成第 2–3 期与第 5–6 期，年度期数仍是 8 期。

• From the 2013 volume the journal has appeared online only, with no printed issue produced, and article numbers took the place of page ranges.自 2013 年卷起，刊物只出电子版，不再印制纸本，文章编号取代了此前的起止页。

• Crossref counts eight issues in volume 31 and again in volume 32, and the figure has held since the move to online-only publication.Crossref 为第 31 卷与第 32 卷各记 8 期，转为纯线上出版后期数一直保持在这个水平。

• Articles now go online as soon as they are ready and are assigned to the issue current at the time, so a queue of page numbers no longer holds a manuscript back.文章就绪即上线，随后编入当期刊次，页码排队不再拖住稿件。

• Access is hybrid. Authors who choose open access pick one of three Creative Commons licences, CC BY, CC BY-NC or CC BY-NC-ND, while those on the subscription route sign a copyright transfer agreement.访问模式为混合型。选择开放获取的作者可在 CC BY、CC BY-NC 与 CC BY-NC-ND 三种知识共享许可中择一，走订阅路线的作者则签署版权转让协议。

• Gold open access accounts for 47.66 percent of the content, and the 2025 Journal Impact Factor is 2.4 against a five-year figure of 2.3.金色开放获取占全部内容的 47.66%，2025 年期刊影响因子为 2.4，五年影响因子为 2.3。

• The Journal Citation Indicator stands at 0.52 and the percentile at 51, with 2,342 citations to the title and 41 articles in 2025, while the acceptance rate is 28 percent and full-text views reached 110,953.期刊引文指标为 0.52，百分位为 51，总被引 2342 次，2025 年发文 41 篇，接收率 28%，全文浏览约 11.1 万次。

• A cited half-life of 11 years is long for a title of this size, and it points to continued use of older work on vessel biology.被引半衰期为 11 年，在这一体量的期刊里算长，说明早年关于血管生物学的工作仍被持续使用。

• Journal Citation Reports place the journal 51st of 103 in Hematology, a second-quartile position, and 53rd of 100 in Peripheral Vascular Disease, which falls in the third quartile.Journal Citation Reports 把它排在血液学 103 种期刊中的第 51 位，属第二四分位，在外周血管病 100 种期刊中排第 53 位，属第三四分位。

• Submitting authors in 2025 came mainly from the United States at 59 percent, with Canada at 10, Australia and China at 5 apiece and Denmark at 2, while readers were spread differently, 28 percent in the United States, 24 in China, 6 in the United Kingdom, 5 in Japan and 3 in Germany.2025 年的投稿作者以美国为主，占 59%，加拿大 10%，澳大利亚与中国各占 5%，丹麦 2%。读者分布另是一幅图景，美国 28%，中国 24%，英国 6%，日本 5%，德国 3%。

Editors

• Walter Lee Murfee of the University of Florida holds the editor-in-chief post and sets the editorial line for the title.主编为（Walter Lee Murfee），任职于 University of Florida，负责把握刊物的编辑方向。

• Michael Hickey of Monash University is the deputy editor, working alongside the editor-in-chief on manuscript decisions.副编辑为（Michael Hickey），来自 Monash University，与主编共同处理稿件取舍。

• Two consulting editors advise the office, William F. Jackson of Michigan State University and Geraldine Clough of the University of Southampton in the United Kingdom.顾问编辑有两位，分别是 Michigan State University 的（William F. Jackson）与英国 University of Southampton 的（Geraldine Clough）。

• Seventeen associate editors handle manuscripts, and Jing Yan Han of Peking University carries the additional label Associate Editor (Asia).副编辑共 17 人分担稿件处理，Peking University 的（Jing Yan Han）另标注为 Associate Editor (Asia)。

• Claudine Bonder at Adelaide University works on tumour microcirculation and the migration of immune cells through vessel walls, Jerome Breslin at the University of South Florida on inflammation and the endothelial barrier, and John Chappell at Virginia Tech on angiogenesis and pericytes.Adelaide University 的（Claudine Bonder）研究肿瘤微循环与免疫细胞穿越血管壁的迁移，University of South Florida 的（Jerome Breslin）研究炎症与内皮屏障，Virginia Tech 的（John Chappell）研究血管新生与周细胞。

• Ed Eringa divides time between Amsterdam UMC and Maastricht University, and Nikolaos Tsoukias at Florida International University works on bioengineering and computational modelling of microvascular flow.（Ed Eringa）同时任职于 Amsterdam UMC 与 Maastricht University，Florida International University 的（Nikolaos Tsoukias）从事微血管流动的生物工程与计算建模。

• An editorial board of ninety-six members is drawn from twelve countries, with the United States largest and the United Kingdom, Canada, Australia and Japan close behind, while China, the Netherlands, Germany, Denmark, Hungary, Chile and Spain also appear on the roster.编委会由 96 人组成，来自 12 个国家，美国所占人数最多，其后依次是英国与加拿大，澳大利亚与日本也在前列。欧洲另有荷兰与德国，丹麦及匈牙利也有人选，亚洲一侧有中国，智利与西班牙同样出现在名单里。

• Donald Welsh of the University of Western Ontario held the editor-in-chief role before the current appointment.（Donald Welsh）在现任主编之前担任主编，任职于 University of Western Ontario。

• The editorial office is run by Binnazer Madisa, and the shared mailbox for correspondence is (miccoffice@wiley.com).编辑办公室由（Binnazer Madisa）主持，对外通信的公共邮箱为（miccoffice@wiley.com）。

• Submissions go through Wiley Research Exchange at authors.wiley.com/journal/MICC, and authors may name up to five preferred reviewers.投稿经 Wiley Research Exchange 提交，入口为 authors.wiley.com/journal/MICC，作者至多可推荐 5 位审稿人。

• Every submission is screened for textual overlap on receipt, and the Free Format route lets authors follow any consistent reference style. A revised manuscript must arrive with an author response that answers each reviewer point in turn.来稿在接收时即做重复度筛查，Free Format 投稿通道允许作者任选一种参考文献体例，只要全篇一致。修改稿则须附作者回复，逐条回应审稿意见。

• Structured abstracts run to 200 words under Objective, Methods, Results and Conclusions, titles are held to 150 characters and running titles to 40.结构化摘要不超过 200 词，分目的、方法、结果与结论四段，标题限于 150 个字符，眉题限于 40 个字符。

• After the discussion, every paper closes with a three-sentence section called Perspectives that states the clinical or translational significance of the findings.讨论之后，每篇论文都要加一个三句话的小节，名为 Perspectives，说明结果在临床或转化上的意义。

• Reviews and invited reviews usually run 4,000 to 5,000 words with abstracts of no more than 250 words, and many are tied to a special issue, a symposium or a conference.综述与约稿综述通常为 4000 至 5000 词，摘要不超过 250 词，不少来自专刊、研讨会或会议的组稿。

• Turnaround figures for 2025 put the median time to first decision at 17 days, submission to acceptance at 124 days and acceptance to online publication at 15 days.2025 年的流程数据显示，投稿到首次决定的中位时间为 17 天，投稿到接收为 124 天，接收到上线为 15 天。